Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pediatric Studies Of Systemic Atopic Dermatitis Drugs Should Start Earlier, US FDA Says

Apr 12 2018

• By Sue Sutter

Small kid taking a view of a plastic house.

Related Content

'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says

Nov 14 2017

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

Jan 09 2018

Pediatric Drug Development A Priority For US FDA’s New Oncology Center Of Excellence

Feb 22 2017

Pediatric Studies: FDA Pushes Earlier Dermatitis Trials; Will It Push Others Next?

Mar 16 2015

Additional Topics

United States Pediatrics Drug Approval Standards Regulation Dermatology BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window